SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (998)5/19/1998 6:21:00 PM
From: seminole  Read Replies (1) | Respond to of 1826
 
R.B.

<<"We are encouraged that, with a
tolerable toxicity profile, we have achieved blood levels of MGI 114 that are consistent with those required for antitumor
activity in laboratory studies with human tumor cells.">>>

S. Gail Eckhardt, M.D., must have studied public
speaking at the same place as Greenspan. What about
the tumors?

richard



To: Russian Bear who wrote (998)5/19/1998 6:32:00 PM
From: WTDEC  Read Replies (1) | Respond to of 1826
 
Hi Russian Bear. I've been travelling. but found a hotel in Denver with a terminal. However, they close the business room soon (still waiting for the new IBM portable I ordered) . Enjoyed today's action in both LGND and MOGN. Hope all is well. Do you think it is time to give a bath?? :-)

Regards,

Walter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News